Sirolimus-eluting stent implantation for treatment of proximal left anterior descending coronary artery lesions: Long-term outcome and predictors of adverse cardiac events

2007 ◽  
Vol 70 (3) ◽  
pp. 368-373 ◽  
Author(s):  
Cheol Whan Lee ◽  
Chong-Hiok Tan ◽  
Jon Suh ◽  
Se-Whan Lee ◽  
Duk-Woo Park ◽  
...  
Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Henning Kelbćk ◽  
Leif Thuesen ◽  
Skejby Sygehus ◽  
Lene Kløvgaard ◽  
Steffen Helqvist ◽  
...  

Background - The long-term outcome of patients with complex coronary artery lesions treated with drug-eluting stents is unknown. This study evaluated the 3-year clinical outcome of patients randomized in the SCANDSTENT study to have sirolimus-eluting stents (SES) or bare metal stents (BMS) implanted in their complex lesions. Methods and Results - We randomly assigned 322 patients with symptomatic coronary artery disease and either a total coronary occlusion, a lesion located in a bifurcation, in an ostial or in an angulated segment of the coronary artery to have SES or BMS implanted. At 3 years, major adverse cardiac events had occurred in 24 patients (15%) in the SES group and in 59 patients (37%) in the BMS group ( P <0.001). Four versus 2 patients suffered a cardiac death (NS), and 5 versus 1 died of a non-cardiac disease (NS). Six patients in the SES group versus 15 patients in the BMS group suffered a myocardial infarction ( P <0.05), and target lesion revascularization was performed in 8 patients (4.9%) versus 53 patients (33.8%), respectively ( P <0.001); of these 4 in the SES versus 7 in the BMS group was performed between 1 and 3 years after the index treatment (NS). According to revised definitions, stent thrombosis occurred in 5 patients (3.1%) in the SES group and in 7 patients (4.4%) in the BMS group (NS); very late stent thromboses were observed in 4 versus 1 patient. Conclusions - A continued benefit was observed out to 3 years after implantation of SES in patients with complex coronary artery lesions. Late adverse events occurred less frequently in the SES group, and stent thromboses occurred rarely after 1 year.


2008 ◽  
Vol 51 (21) ◽  
pp. 2011-2016 ◽  
Author(s):  
Henning Kelbæk ◽  
Lene Kløvgaard ◽  
Steffen Helqvist ◽  
Jens F. Lassen ◽  
Lars R. Krusell ◽  
...  

Heart ◽  
2001 ◽  
Vol 86 (2) ◽  
pp. 193-198
Author(s):  
M Albertal ◽  
G Van Langenhove ◽  
E Regar ◽  
I P Kay ◽  
D Foley ◽  
...  

OBJECTIVETo study the relation between moderate coronary dissections, coronary flow velocity reserve (CFVR), and long term outcome.METHODS523 patients undergoing balloon angioplasty and sequential intracoronary Doppler measurements were examined as part of the DEBATE II trial (Doppler endpoints balloon angioplasty trial Europe). After successful balloon angioplasty, patients were randomised to stenting or no further treatment. Dissections were graded at the core laboratory by two observers and divided into four categories: none, mild (type A-B), moderate (type C), severe (types D to F). Patients with severe dissections (n = 128) or without available reference vessel CFVR (n = 139) were excluded. The remaining 256 patients were divided into two groups according to the presence (group A, n = 45) or absence (group B, n = 211) of moderate dissection.RESULTSFollowing balloon angioplasty, there was no difference in CFVR between the two groups. At 12 months follow up, a higher rate of major adverse cardiac events was observed overall in group A than in group B (10 (22%)v 23 (11%), p = 0.041). However, the risk of major adverse events was similar in the subgroups receiving balloon angioplasty (group A, 6 (19%) v group B, 16 (16%), NS). Among group A patients, the adverse events risk was greater in those randomised to stenting (odds ratios 6.603v 1.197, p = 0.046), whereas there was no difference in risk if the group was analysed according to whether the CFVR was < 2.5 or ⩾ 2.5 after balloon angioplasty.CONCLUSIONSModerate dissections left untreated result in no increased risk of major adverse cardiac events. Additional stenting does not improve the long term outcome.


Circulation ◽  
2007 ◽  
Vol 116 (2) ◽  
pp. 158-162 ◽  
Author(s):  
Alaide Chieffo ◽  
Seung J. Park ◽  
Marco Valgimigli ◽  
Young H. Kim ◽  
Joost Daemen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document